Digital DIA 2024: Charting new horizons in patient-centered R&D In its 60th year, the Drug Information Association (DIA) global annual meeting
R&D DIA 2023 – a “patients included” global event The 2023 Drug Information Association global annual meeting was the ideal setting to put our collective heads together and pool
Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was
News Bayer's asundexian starts EU review for ischaemic stroke The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
